Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Novo Nordisk A/S securities between November 2, 2022 and December 19, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback